These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9533478)

  • 1. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
    Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
    Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Adamovicz JJ; Amemiya K; Fast RL; Miller L; Opal SM; Palardy J; Parejo NA; Sörgel F; Kinzig-Schippers M; Drusano GL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3276-84. PubMed ID: 24687492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague.
    Anderson PE; Olson RM; Willix JL; Anderson DM
    Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
    Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
    Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
    Vagima Y; Gur D; Erez N; Achdout H; Aftalion M; Levy Y; Zauberman A; Tidhar A; Gutman H; Lazar S; Israely T; Paran N; Melamed S; Brosh-Nissimov T; Chitlaru T; Sagi I; Mamroud E
    Sci Rep; 2020 Nov; 10(1):19116. PubMed ID: 33154422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
    Cabanel N; Bouchier C; Rajerison M; Carniel E
    Int J Antimicrob Agents; 2018 Feb; 51(2):249-254. PubMed ID: 29030266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Doxycycline in the prevention of experimental plague induced by plague microbe variants].
    Samokhodkina ED; Ryzhko IV; Shcherbaniuk AI; Kasatkina IV; Tsuraeva RI; Zhigalova TA
    Antibiot Khimioter; 1992 Nov; 37(11):26-8. PubMed ID: 1300930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.